We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WHD:NYSECactus, Inc. Class A Common Stock Analysis

Data as of 2026-09-16 - not real-time

$69.85

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cactus, Inc. is priced at $69.85 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 9.4%. Momentum indicators put RSI at 54.5 (neutral) with MACD reading bearish. Watch $65.70 as support and $74.07 as the nearer resistance level.
Valuation screens as overvalued: a P/E of 56.3 sits above the sector average of 18.3. Revenue is growing at 64.3% on a 12.0% profit margin. The 0.89% dividend yield looks covered by current payout levels.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 40.2%, a beta of 1.12 and a maximum drawdown of 23.5%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Cactus stock has more than doubled over the past five years, yet its current price sits between two conflicting...Shares of Cactus, Inc. WHD have been strong performers lately, with the stock up 31.7% over the past month. The stock...Cactus WHD reported earnings 30 days ago.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 55.50
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 56.3 versus sector average of 18.3
  • Trading above the 200-day average of 55.50

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 56.3 versus sector average of 18.3
  • Revenue growth of +64.3%
  • 30-day volatility of 40.2%

Key Metrics & Analysis

Financial Health

Revenue Growth64.30%
Profit Margin11.98%
P/E Ratio56.3
ROE13.11%
ROA7.41%
Debt/Equity3.30
P/B Ratio3.9
Op. Cash Flow$366.9M
Free Cash Flow$129.3M
Industry P/E18.3

Technical Analysis

TrendBullish
RSI54.5
Support$65.70
Resistance$74.07
MA 20$69.71
MA 50$64.09
MA 200$55.50
MACDBearish
VolumeStable
Fear & Greed Index90.88

Valuation

Fair Value$66.58
Target Price$69.22
Upside/Downside-0.90%
GradeOvervalued
TypeGrowth
Dividend Yield0.89%

Risk Assessment

Beta1.12
Volatility40.19%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.